Libre, Lance T.
HRN: 20-91-67 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/08/2022
CO-AMOXICLAV 457MG/5ML, 70ML SUSPENSION (BOT)
12/08/2022
12/14/2022
PO
2 Ml
Q 12
URTI
Waiting Final Action
Indication: Empiric Type of Infection: URTI Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes